﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2015v2.1">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2016-08-29T15:35:06-05:00</ReturnTs>
    <TaxPeriodEndDt>2015-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>271728945</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>PKF O'CONNOR DAVIES LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>665 FIFTH AVENUE</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10022</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2015-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>133859563</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>THE ZACHARY &amp; ELIZABETH M FISHER CENTER</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>FOR ALZHEIMER'S RESEARCH FOUNDATION</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>ZACH</BusinessNameControlTxt>
      <PhoneNum>2129151321</PhoneNum>
      <USAddress>
        <AddressLine1Txt>110 EAST 42ND STREET NO 16 FL</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10017</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>KENT KAROSEN</PersonNm>
      <PersonTitleTxt>PRESIDENT &amp; CEO</PersonTitleTxt>
      <PhoneNum>2129151321</PhoneNum>
      <SignatureDt>2016-08-29</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>GARRETT M HIGGINS</PreparerPersonNm>
      <PTIN>P00543209</PTIN>
      <PhoneNum>2122862600</PhoneNum>
      <PreparationDt>2016-08-29</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2015</TaxYr>
    <BuildTS>2016-12-15 16:53:06Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="10">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <DoingBusinessAsName>
        <BusinessNameLine1Txt>ALZHEIMER'S RESEARCH FDNFISHER CTR</BusinessNameLine1Txt>
      </DoingBusinessAsName>
      <PrincipalOfficerNm>KENT KAROSEN</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>110 EAST 42ND STREET NO 16 FL</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10017</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>9554713</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.ALZINFO.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1995</FormationYr>
      <LegalDomicileStateCd>NY</LegalDomicileStateCd>
      <ActivityOrMissionDesc>SEE SCHEDULE O</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>15</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>14</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>8</TotalEmployeeCnt>
      <TotalVolunteersCnt>14</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>3230379</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>3414828</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>0</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>921776</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>771257</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>0</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>0</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>4152155</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>4186085</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>2025025</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>2625000</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>946819</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>900659</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>225584</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>429678</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>518436</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>3401522</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>4044095</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>750633</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>141990</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>22753833</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>22274437</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>71645</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>120896</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>22682188</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>22153541</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>SEE SCHEDULE O.THE ZACHARY AND ELIZABETH M. FISHER ALZHEIMER'S RESEARCH FOUNDATION IS DEDICATED TO ATTACKING THE SCOURGE OF ALZHEIMER'S DISEASE THROUGH A 3-PRONGED ASSAULT FOCUSED ON UNDERSTANDING THE CAUSE OF ALZHEIMER'S DISEASE; IMPROVING THE CARE OF PEOPLE LIVING WITH THE DISEASE TO ENHANCE THEIR QUALITY OF LIFE AND THAT OF THEIR CAREGIVERS AND FAMILIES; AND FINDING A CURE FOR THIS DEVASTATING DISEASE.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>2450000</ExpenseAmt>
      <GrantAmt>2450000</GrantAmt>
      <Desc>A GRANT WAS MADE TO THE FISHER CENTER FOR ALZHEIMER'S RESEARCH AT THE ROCKEFELLER UNIVERSITY FOR NEUROLOGICAL RESEARCH INTO THE CAUSES OF ALZHEIMER'S AND POTENTIAL NEW PHARMACOLOGICAL TREATMENT OPTIONS. THE LAB IS UNDER THE DIRECTION OF NOBEL LAUREATE DR. PAUL GREENGARD WHO HEADS A TEAM OF OVER 50 SCIENTISTS WORLDWIDE. HIS SEMINAL FINDINGS HAVE BEEN THE BASIS OF MANY OF TODAY'S ALZHEIMER'S INVESTIGATIONS WORLDWIDE.FISHER SCIENTISTS DISCOVERED THAT A PORTION OF THE PROTEIN APP (THE INTRACELLULAR DOMAIN CALLED AICD) DOWNREGULATES THE PROTEIN WAVE1 AS PART OF A NOVEL MECHANISM TO LIMIT ABETA PRODUCTION. THE AICD BINDS TO REGULATORY ELEMENTS OF THE WAVE1 GENE AND NEGATIVELY REGULATES ITS EXPRESSION. WAVE1 ALSO INTERACTS AND COLOCALIZES WITH APP IN THE GOLGI APPARATUS. EXPERIMENTALLY REDUCING WAVE1 IN CULTURED CELLS REDUCED CELL-SURFACE APP, THEREBY REDUCING THE PRODUCTION OF ABETA. WAVE1 DOWNREGULATION WAS OBSERVED IN MODELS OF AD. REDUCTION OF WAVE1 GENE EXPRESSION DRAMATICALLY REDUCED ABETA LEVELS AND RESTORED MEMORY DEFICITS IN A MOUSE MODEL OF AD. REMARKABLY, A DECREASE IN AMOUNTS OF IN THE MESSENGER RNA OF WAVE1, CALLED WASF1, WAS ALSO OBSERVED IN HUMAN AD BRAINS, SUGGESTING CLINICAL RELEVANCE OF THE NEGATIVE FEEDBACK CIRCUIT INVOLVED IN HOMEOSTATIC REGULATION OF A? PRODUCTION. THIS FINDING IS SIGNIFICANT AS IT PROVIDES AN OPPORTUNITY TO CREATE NEW TREATMENTS THAT WILL PROTECT THE BRAIN BY ACTIVATING THE PATHWAY WE DISCOVERED, WHICH WILL PREVENT BETA AMYLOID FORMATION. THIS WORK WAS PUBLISHED IN THE JOURNAL NATURE MEDICINE. THIS STUDY HAS ALSO BEEN WELL RECEIVED WORLDWIDE.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>829356</ExpenseAmt>
        <Desc>THE FISHER CENTER ALZHEIMER'S INFORMATION PROGRAM PROMOTES PUBLIC AWARENESS AND EDUCATION ABOUT ALZHEIMER'S. THE PROGRAM USES BOTH ONLINE AND TRADITIONAL MEDIA CONDUITS TO KEEP THE PUBLIC INFORMED WITH COMPREHENSIVE, RELIABLE INFORMATION ABOUT ALZHEIMER'S, RECENT RESEARCH STUDIES, TREATMENTS AND DISEASE MANAGEMENT APPROACHES THROUGH ITS PUBLICATION, PRESERVING YOUR MEMORY MAGAZINE (CIRCULATION: 100,000; PUBLISHED THREE TIMES A YEAR) DISTRIBUTED TO HEALTH AND COMMUNITY ORGANIZATIONS NATIONWIDE. THE FISHER CENTER HAS A WEBSITE (ALZINFO.ORG) AND DISTRIBUTES BI-WEEKLY E-NEWSLETTERS OF EXPERT-REVIEWED ALZHEIMER'S NEWS AND RESEARCH TWICE EVERY MONTH TO OVER 15,000 SUBSCRIBERS. THE WEBSITE IS UPDATED REGULARLY WITH FRESH CONTENT AND INFORMATION ABOUT THE FOUNDATION. IN 2015, THE WEBSITE HAD 620,000 UNIQUE VISITORS ANNUALLY.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>125000</ExpenseAmt>
        <GrantAmt>125000</GrantAmt>
        <Desc>A GRANT WAS MADE TO THE FISHER EDUCATION AND RESOURCES PROGRAM AT NYU LANGONE SCHOOL OF MEDICINE FOR CLINICAL RESEARCH INTO THE EFFICACY OF BOTH PHARMACOLOGICAL AND NON-PHARMACOLOGICAL TREATMENT OPTIONS FOR ALZHEIMER'S DISEASE. THE CENTER IS UNDER THE DIRECTION OF DR. BARRY REISBERG, M.D., INTERNATIONALLY KNOWN EXPERT IN THE CARE OF ALZHEIMER'S PATIENTS. THE TOOLS AND SCALES FOR RESEARCH EVALUATION AND DISEASE MANAGEMENT DEVELOPED BY THIS PROGRAM ARE USED IN CARE SETTINGS AROUND THE WORLD. DR. REISBERG AND HIS COLLEAGUES AT THE CENTER HAVE PUBLISHED INNUMERABLE ARTICLES ON BEST CARE MODALITIES THAT MAY SLOW THE PROGRESSION AND IMPROVE THE QUALITY OF LIFE FOR THOSE WITH ALZHEIMER'S. IN 2015, FISHER CENTER RESEARCHERS AT NYU COMPLETED THE DESIGN OF TWO NEW STUDIES ENTITLED, "HEALTH OUTCOMES OF A 28 WEEK COMPREHENSIVE, INDIVIDUALIZED, PATIENT CENTERED MANAGEMENT PROGRAM (CIPCM) IN MODERATELY SEVERE ALZHEIMER'S PATIENTS ON MEMANTINE AND "HEALTH OUTCOMES OF A 24 WEEK EXTENDED COMPREHENSIVE, INDIVIDUALIZED, PATIENT CENTERED MANAGEMENT PROGRAM IN MODERATELY SEVERE ALZHEIMER'S PATIENTS ON MEMANTINE."</Desc>
      </ProgSrvcAccomActy3Grp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>181091</ExpenseAmt>
        <GrantAmt>50000</GrantAmt>
        <Desc>THE FOUNDATION PROMOTES OTHER SERVICES AND EDUCATIONAL AWARENESS ACTIVITIES TO SERVE THE ALZHEIMER'S COMMUNITY. THIS INCLUDES A GRANT TO KAROLINSKA INSTITUTE IN SWEDEN FOR RESEARCH INTO THE CAUSE AND TREATMENT OF NEUROLOGICAL DISORDERS SUCH AS ALZHEIMER'S.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <TotalOtherProgSrvcExpenseAmt>181091</TotalOtherProgSrvcExpenseAmt>
      <TotalOtherProgSrvcGrantAmt>50000</TotalOtherProgSrvcGrantAmt>
      <TotalProgramServiceExpensesAmt>3585447</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="RetDoc1040000001">0</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">1</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="RetDoc1040500001">1</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="RetDoc1040500001">1</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd referenceDocumentId="RetDoc1040500001">0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>0</FundraisingActivitiesInd>
      <GamingActivitiesInd>0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">1</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">0</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</PYExcessBenefitTransInd>
      <LoanOutstandingInd referenceDocumentId="RetDoc1042800001">0</LoanOutstandingInd>
      <GrantToRelatedPersonInd referenceDocumentId="RetDoc1042800001">0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd referenceDocumentId="RetDoc1042800001">1</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd referenceDocumentId="RetDoc1042900001">1</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd referenceDocumentId="RetDoc1042900001">0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd>0</DisregardedEntityInd>
      <RelatedEntityInd>0</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>3</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>8</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>15</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>14</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>1</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>0</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>0</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>1</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>AZ</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>UT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>IL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MO</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NJ</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NY</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>OH</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>PA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>RI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>TX</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>VA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MD</StatesWhereCopyOfReturnIsFldCd>
      <OwnWebsiteInd>X</OwnWebsiteInd>
      <OtherWebsiteInd>X</OtherWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>FEKADU TADDESE</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>2129151324</PhoneNum>
        <USAddress>
          <AddressLine1Txt>110 EAST 42ND STREET FL 16</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>BARRY SLOANE</PersonNm>
        <TitleTxt>CHAIRMAN/TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>HOWARD LUTNICK</PersonNm>
        <TitleTxt>CO-VICE CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MARTIN EDELMAN</PersonNm>
        <TitleTxt>CO-VICE CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KENT KAROSEN</PersonNm>
        <TitleTxt>PRESIDENT/CEO</TitleTxt>
        <AverageHoursPerWeekRt>30.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>280000</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MURRAY RUBIN</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR MANNY ALVAREZ</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR E RATCLIFFE ANDERSON JR</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>GERRY BYRNE</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>HADLEY FISHER</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BETSY GOTBAUM</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR PAUL GREENGARD</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JAMES L NEDERLANDER</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RICHARD J SALEM</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR MOSHE SHIKE</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DAVID HW TURNER</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ALAN WHITE</PersonNm>
        <TitleTxt>EXECUTIVE VICE PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>111418</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>15108</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>391418</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>15108</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>2</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>THE STAYWELL COMPANY LLC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>407 NORWALK STREET</AddressLine1Txt>
            <CityNm>GREENSBORO</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>27407</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>MAGAZINE PUBLISHING</ServicesDesc>
        <CompensationAmt>210000</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>1</CntrctRcvdGreaterThan100KCnt>
      <FederatedCampaignsAmt>431767</FederatedCampaignsAmt>
      <AllOtherContributionsAmt>2983061</AllOtherContributionsAmt>
      <NoncashContributionsAmt>72344</NoncashContributionsAmt>
      <TotalContributionsAmt>3414828</TotalContributionsAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>491655</TotalRevenueColumnAmt>
        <ExclusionAmt>491655</ExclusionAmt>
      </InvestmentIncomeGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>5648143</SecuritiesAmt>
        <OtherAmt>87</OtherAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>5368628</SecuritiesAmt>
        <OtherAmt>0</OtherAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>279515</SecuritiesAmt>
        <OtherAmt>87</OtherAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>279602</TotalRevenueColumnAmt>
        <ExclusionAmt>279602</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>4186085</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>0</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>771257</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>2575000</TotalAmt>
        <ProgramServicesAmt>2575000</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>50000</TotalAmt>
        <ProgramServicesAmt>50000</ProgramServicesAmt>
      </ForeignGrantsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>280000</TotalAmt>
        <ProgramServicesAmt>210000</ProgramServicesAmt>
        <ManagementAndGeneralAmt>28000</ManagementAndGeneralAmt>
        <FundraisingAmt>42000</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>532653</TotalAmt>
        <ProgramServicesAmt>361147</ProgramServicesAmt>
        <ManagementAndGeneralAmt>62892</ManagementAndGeneralAmt>
        <FundraisingAmt>108614</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>6631</TotalAmt>
        <ProgramServicesAmt>4496</ProgramServicesAmt>
        <ManagementAndGeneralAmt>783</ManagementAndGeneralAmt>
        <FundraisingAmt>1352</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>41664</TotalAmt>
        <ProgramServicesAmt>28249</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4919</ManagementAndGeneralAmt>
        <FundraisingAmt>8496</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>39711</TotalAmt>
        <ProgramServicesAmt>26924</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4689</ManagementAndGeneralAmt>
        <FundraisingAmt>8098</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>22000</TotalAmt>
        <ManagementAndGeneralAmt>22000</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>77443</TotalAmt>
        <ManagementAndGeneralAmt>77443</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>234285</TotalAmt>
        <ProgramServicesAmt>234285</ProgramServicesAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>19821</TotalAmt>
        <FundraisingAmt>19821</FundraisingAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>51805</TotalAmt>
        <ManagementAndGeneralAmt>17354</ManagementAndGeneralAmt>
        <FundraisingAmt>34451</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>66526</TotalAmt>
        <ProgramServicesAmt>66526</ProgramServicesAmt>
      </InformationTechnologyGrp>
      <TravelGrp>
        <TotalAmt>29816</TotalAmt>
        <ProgramServicesAmt>26765</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2120</ManagementAndGeneralAmt>
        <FundraisingAmt>931</FundraisingAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>429</TotalAmt>
        <ManagementAndGeneralAmt>429</ManagementAndGeneralAmt>
      </ConferencesMeetingsGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>1661</TotalAmt>
        <ManagementAndGeneralAmt>1661</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>6686</TotalAmt>
        <ManagementAndGeneralAmt>6686</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>PAYROLL PROCESSING FEES</Desc>
        <TotalAmt>1068</TotalAmt>
        <ManagementAndGeneralAmt>1068</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>6896</TotalAmt>
        <ProgramServicesAmt>2055</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3020</ManagementAndGeneralAmt>
        <FundraisingAmt>1821</FundraisingAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>4044095</TotalAmt>
        <ProgramServicesAmt>3585447</ProgramServicesAmt>
        <ManagementAndGeneralAmt>233064</ManagementAndGeneralAmt>
        <FundraisingAmt>225584</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>429613</BOYAmt>
        <EOYAmt>907961</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>10137953</BOYAmt>
        <EOYAmt>7834747</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>537072</BOYAmt>
        <EOYAmt>596924</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <AccountsReceivableGrp>
        <BOYAmt>442183</BOYAmt>
        <EOYAmt>530299</EOYAmt>
      </AccountsReceivableGrp>
      <LandBldgEquipCostOrOtherBssAmt>9436</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>6722</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>2952</BOYAmt>
        <EOYAmt>2714</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>11204060</BOYAmt>
        <EOYAmt>12401792</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <TotalAssetsGrp>
        <BOYAmt>22753833</BOYAmt>
        <EOYAmt>22274437</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>71645</BOYAmt>
        <EOYAmt>120896</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>71645</BOYAmt>
        <EOYAmt>120896</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>22145116</BOYAmt>
        <EOYAmt>21556617</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TemporarilyRstrNetAssetsGrp>
        <BOYAmt>537072</BOYAmt>
        <EOYAmt>596924</EOYAmt>
      </TemporarilyRstrNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>22682188</BOYAmt>
        <EOYAmt>22153541</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>22753833</BOYAmt>
        <EOYAmt>22274437</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>141990</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>-670637</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>0</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>2708586</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>3538454</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>4890186</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>3230379</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>3414828</CurrentTaxYearAmt>
        <TotalAmt>17782433</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>2708586</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>3538454</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>4890186</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>3230379</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>3414828</CurrentTaxYearAmt>
        <TotalAmt>17782433</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>1904622</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>15877811</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>270639</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>189415</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>308109</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>392203</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>491655</CurrentTaxYearAmt>
        <TotalAmt>1652021</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <TotalSupportAmt>19434454</TotalSupportAmt>
      <PublicSupportCY170Pct>0.81700</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.73270</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>9436</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>6722</DepreciationAmt>
        <BookValueAmt>2714</BookValueAmt>
      </EquipmentGrp>
      <TotalBookValueLandBuildingsAmt>2714</TotalBookValueLandBuildingsAmt>
      <FederalIncomeTaxLiabilityAmt>0</FederalIncomeTaxLiabilityAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>3986369</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>-670637</NetUnrealizedGainsInvstAmt>
      <DonatedServicesAndUseFcltsAmt>548364</DonatedServicesAndUseFcltsAmt>
      <RevenueNotReportedAmt>-122273</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>4108642</RevenueSubtotalAmt>
      <InvestmentExpensesNotIncldAmt>77443</InvestmentExpensesNotIncldAmt>
      <RevenueNotReportedFinclStmtAmt>77443</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>4186085</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>4515016</TotExpnsEtcAuditedFinclStmtAmt>
      <DonatedServicesUseFcltsAmt>548364</DonatedServicesUseFcltsAmt>
      <ExpensesNotReportedAmt>548364</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>3966652</ExpensesSubtotalAmt>
      <InvestmentExpensesNotIncld2Amt>77443</InvestmentExpensesNotIncld2Amt>
      <ExpensesNotRptFinclStmtAmt>77443</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>4044095</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES - THE FOUNDATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. MANAGEMENT HAS DETERMINED THAT THE FOUNDATION HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION OR DISCLOSURE. THE FOUNDATION IS NO LONGER SUBJECT TO EXAMINATIONS BY THE APPLICABLE TAXING JURISDICTIONS FOR TAX YEARS PRIOR TO 2012.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="RetDoc1040500001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>EUROPE</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>GRANTS</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>RESEARCH GRANT TO KAROLINSKA INSTITUTE</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>50000</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <SubtotalOfficesCnt>0</SubtotalOfficesCnt>
      <SubtotalEmployeesCnt>0</SubtotalEmployeesCnt>
      <ContinutationTotalOfficeCnt>0</ContinutationTotalOfficeCnt>
      <ContinutationTotalEmployeeCnt>0</ContinutationTotalEmployeeCnt>
      <TotalOfficeCnt>0</TotalOfficeCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <SubtotalSpentAmt>50000</SubtotalSpentAmt>
      <ContinuationSpentAmt>0</ContinuationSpentAmt>
      <TotalSpentAmt>50000</TotalSpentAmt>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>EUROPE</RegionTxt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
        <CashGrantAmt>50000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>WIRE TRANSFER</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <Total501c3OrgCnt>1</Total501c3OrgCnt>
      <TotalOtherOrgCnt>0</TotalOtherOrgCnt>
      <TransferToForeignCorpInd>0</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>0</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>0</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>0</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>0</ForeignPartnershipInd>
      <BoycottCountriesInd>0</BoycottCountriesInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>RESEARCH WILL BE CARRIED OUT BY THE KAROLINSKA INSTITUTE UNDER THE DIRECTION OF DR. PER SVENNINGSSON TO ELUCIDATE THE MOLECULAR MECHANISMS OF THE ACTION IN THE BRAIN RELATING TO THE CAUSE AND TREATMENT OF NEUROLOGICAL DISORDERS SUCH AS ALZHEIMER'S DISEASE. THE FOUNDATION REQUIRES THE GRANTEE TO SUBMIT AN INTERIM 6-MONTH REPORT ON THE PROGRESS OF THEIR INVESTIGATIONS AS WELL AS A FINAL REPORT UPON COMPLETION OF THE TERM OF THE AGREEMENT.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 3</FormAndLineReferenceDesc>
        <ExplanationTxt>EXPENDITURES ARE RECOGNIZED UNDER ACCRUAL BASIS OF ACCOUNTING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART II, LINE 1, COLUMN(E)</FormAndLineReferenceDesc>
        <ExplanationTxt>THE METHOD USED TO ACCOUNT FOR CASH GRANTS ON THE ORGANIZATION'S FINANCIAL STATEMENTS IS ACCRUAL METHOD.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleF>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>THE ROCKEFELLER UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1230 YORK AVENUE</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10021</ZIPCd>
        </USAddress>
        <RecipientEIN>131624158</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>2450000</CashGrantAmt>
        <PurposeOfGrantTxt>SEE PART IV</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>NYU MEDICAL CENTER</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>550 FIRST AVENUE</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10016</ZIPCd>
        </USAddress>
        <RecipientEIN>135562308</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>125000</CashGrantAmt>
        <PurposeOfGrantTxt>SEE PART IV</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>2</Total501c3OrgCnt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION MONITORS THE USE OF GRANT FUNDS IN THE US BY RECEIVING PERIODIC PROGRESS REPORTS ON THE RESEARCH CONDUCTED AND ANY FINDINGS PUBLISHED AS A RESULT OF THIS FUNDING. THE FISHER CENTER FOR ALZHEIMER'S DISEASE RESEARCH AT THE ROCKEFELLER UNIVERSITY SUBMITS A REPORT AT EACH GENERAL BOARD MEETING WHICH IS INCORPORATED INTO THE MINUTES OF THE MEETING. THE FISHER EDUCATIONAL AND RESOURCES PROGRAM AT NYU SCHOOL OF MEDICINE REPORTS AT THE END OF THE FUNDING PERIOD IN THEIR REQUEST FOR FURTHER FUNDING ON THE PROGRESS TO DATE OF THE RESEARCH ACTIVITIES SUPPORTED BY THE FOUNDATION.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, SCHEDULE I, PART II, COLUMN(H)</FormAndLineReferenceDesc>
        <ExplanationTxt>PURPOSE OF GRANT THE ROCKEFELLER UNIVERSITY: GRANTS TO THE FISHER CENTER FOR ALZHEIMER'S DISEASE RESEARCH AT THE ROCKEFELLER UNIVERSITY FOR NEUROLOGICAL RESEARCH INTO THE CAUSES OF ALZHEIMER'S AND POTENTIAL NEW PHARMACOLOGICAL TREATMENT OPTIONS. NYU MEDICAL CENTER: NYU GRANT TO FISHER EDUCATION AND RESOURCES PROGRAM AT NY UNIVERSITY SCHOOL OF MEDICINE FOR CLINICAL RESEARCH INTO THE EFFICACY OF MEMANTINE AND COMPREHENSIVE INDIVIDUALIZED PATIENT-CENTERED MANAGEMENT OF ALZHEIMER'S DISEASE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <Form990OfOtherOrganizationsInd>X</Form990OfOtherOrganizationsInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>1</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>KENT KAROSEN</PersonNm>
        <TitleTxt>PRESIDENT/CEO</TitleTxt>
        <BaseCompensationFilingOrgAmt>190000</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>90000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>0</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>0</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>280000</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 7</FormAndLineReferenceDesc>
        <ExplanationTxt>IN 2015, THE PRESIDENT/CEO WAS AWARDED A BONUS OF $90,000 IN RECOGNITION OF HIS EXCELLENT PERFORMANCE DIRECTING THE INITIATIVES OF THE FOUNDATION. THE BONUS WAS PROVIDED AT THE DISCRETION OF THE BOARD'S COMPENSATION COMMITTEE BY A UNANIMOUS VOTE. IN 2015, AN EXECUTIVE VICE PRESIDENT RECEIVED A PERFORMANCE BONUS IN THE AMOUNT OF $5,000. THE BONUS WAS PROVIDED AT THE DISCRETION OF THE BOARD'S COMPENSATION COMMITTEE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleJ>
    <IRS990ScheduleL documentId="RetDoc1042800001">
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <BusinessName>
            <BusinessNameLine1Txt>CENTURY BANK</BusinessNameLine1Txt>
          </BusinessName>
        </NameOfInterested>
        <RelationshipDescriptionTxt>SEE PART V</RelationshipDescriptionTxt>
        <TransactionAmt>3778718</TransactionAmt>
        <TransactionDesc>SEE PART V</TransactionDesc>
        <SharingOfRevenuesInd>0</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, SCHEDULE L, PART IV</FormAndLineReferenceDesc>
        <ExplanationTxt>RESULTING FROM HIGHLY COMPETITIVE RATES OFFERED BY CENTURY BANK, THE FOUNDATION HOLDS $3,778,718 IN CERTIFICATES OF DEPOSIT WITH CENTURY BANK, WHERE MR. BARRY SLOANE (THE FOUNDATION'S CHAIRMAN/TREASURER) SERVES AS PRESIDENT AND CEO. MR. BARRY SLOANE AND HIS FAMILY MEMBERS OWN MORE THAN 35% OF THE TOTAL COMBINED VOTING POWER OF THE CENTURY BANK. THE ENTIRE BOARD WAS MADE AWARE OF THE CONFLICT WITH MR. SLOANE BEFORE THE CD INVESTMENTS WERE MADE AS WELL AS A CONTINUING DISCLOSURE AT ALL SUBSEQUENT BOARD MEETINGS. THE BOARD UNANIMOUSLY VOTED TO APPROVE THE INVESTMENTS. MR. SLOANE RECUSED HIMSELF FROM THE VOTE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleL>
    <IRS990ScheduleM documentId="RetDoc1042900001">
      <SecuritiesPubliclyTradedGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <ContributionCnt>13</ContributionCnt>
        <NoncashContributionsRptF990Amt>72344</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>FAIR VALUE</MethodOfDeterminingRevenuesTxt>
      </SecuritiesPubliclyTradedGrp>
      <AnyPropertyThatMustBeHeldInd>0</AnyPropertyThatMustBeHeldInd>
      <ReviewProcessUnusualNCGiftsInd>0</ReviewProcessUnusualNCGiftsInd>
      <ThirdPartiesUsedInd>0</ThirdPartiesUsedInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, COLUMN (B):</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION LISTS THE NUMBER OF CONTRIBUTORS IN SCHEDULE M, PART I, LINE 9, COLUMN(B).</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleM>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART I, LINE 1</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION'S FUNDING AND ACTIVITIES ARE DIRECTED TOWARDS THE CAUSE,CARE &amp; CURE OF ALZHEIMER'S DISEASE.THE FOUNDATION FUNDS RESEARCH INTO THE CAUSE AND CURE OF ALZHEIMER'S DISEASE AT THE FISHER CTR FOR ALZHEIMER'S DISEASE RESEARCH AT THE ROCKEFELLER UNIV.,UNDER THE DIRECTION OF NOBEL LAUREATE DR. PAUL GREENGARD,WHOSE FINDINGS HAVE BEEN THE BASIS FOR MUCH OF TODAY'S ALZHEIMER'S INVESTIGATIONS.IT ALSO FUNDS PROJECTS FOR THE CARE OF PEOPLE WITH ALZHEIMER'S DISEASE AND THEIR CAREGIVERS AT THE FISHER ALZHEIMER'S DISEASE EDUCATION AND RESOURCES PROGRAM AT THE NEW YORK UNIVERSITY SCHOOL OF MEDICINE, UNDER THE DIRECTION OF BARRY REISBERG,MD.,PROVIDING NON-PHARMACOLOGICAL TREATMENT OPTIONS TO IMPROVE CARE OF PEOPLE W/ ALZHEIMER'S. THE FOUNDATION PROVIDES EDUCATION &amp; INFORMATION TO THE PUBLIC THROUGH ITS WEBSITE WWW.ALZINFO.ORG,ITS PERIODIC MAGAZINE,PRESERVING YOUR MEMORY, AND A BI-WEEKLY E-NEWSLETTER OF THE LATEST EXPERT-REVIEWED RESEARCH FINDINGS ON CARE AND POSSIBLE TREATMENTS FOR ALZHEIMER'S.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>KENT KAROSEN IS A PARTNER AND EMPLOYEE OF CANTOR FITZGERALD, L.P. AND HE AND HIS ENTITIES, INCLUDING KAROSEN STRATEGIC PARTNERS, HAVE PROVIDED CONSULTING AND OTHER SERVICES FROM TIME TO TIME FOR MR. LUTNICK AND THE CANTOR ENTITIES. MR. LUTNICK ALSO SERVES AS TRUSTEE FOR CERTAIN OF MR. KAROSEN'S TRUSTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11</FormAndLineReferenceDesc>
        <ExplanationTxt>THE 990 IS INITIALLY REVIEWED BY MEMBERS OF THE AUDIT COMMITTEE THAT CONSISTS OF 3 INDEPENDENT TRUSTEES. A COPY OF THE 990 IS THEN FORWARDED ELECTRONICALLY VIA EMAIL TO ALL BOARD MEMBERS AND RELEVANT MANAGEMENT PERSONNEL FOR THEIR REVIEW AND COMMENT BEFORE THE 990 IS FILED. IF ANY REVISIONS ARE REQUIRED, THEY ARE MADE AND THE REVISED 990 IS RESUBMITTED TO ALL BOARD MEMBERS FOR FINAL REVIEW BEFORE FILING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION HAS A CONFLICT OF INTEREST POLICY WHICH IS ANNUALLY MONITORED REQUIRING ALL TRUSTEES TO DISCLOSE ANY POSSIBLE CONFLICT OF INTEREST VIA EMAIL RESPONSE TO THE SENIOR VICE PRESIDENT. THE FOUNDATION REQUIRES THAT ALL TRUSTEES AND STAFF PERSONNEL PROMPTLY AND FULLY DISCLOSE ALL MATERIAL FACTS OF ANY ACTUAL OR POTENTIAL CONFLICT OF INTEREST THAT MAY EXIST AT THE TIME THE TRUSTEE IS APPOINTED OR STAFF PERSONNEL IS HIRED, OR AS THEY MAY ARISE WHILE THE TRUSTEE IS SERVING ON THE BOARD OR THE STAFF PERSONNEL IS EMPLOYED BY THE FOUNDATION. SUCH DISCLOSURES INVOLVING A TRANSACTION, ARRANGEMENT OR DECISION BEING CONSIDERED BY THE BOARD ARE MADE KNOWN TO ALL TRUSTEES. THE BOARD THEN DETERMINES WHETHER A CONFLICT OF INTEREST EXISTS WITH THE INTERESTED PARTY ABSTAINING FROM THE DECISION. IF IT IS DETERMINED THAT NO CONFLICT EXISTS, THEN THE BOARD VOTES ON THE TRANSACTION BUT WITH THE INTERESTED PARTY RECUSING HIMSELF FROM THE DISCUSSION AND VOTE ON SAID MATTER.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION HAS A COMPENSATION COMMITTEE CONSISTING OF 4 INDEPENDENT TRUSTEES TO DETERMINE THE COMPENSATION OF THE PRESIDENT/CEO, EXECUTIVE VICE PRESIDENT AND TOP MANAGEMENT AND KEY EMPLOYEES AT LEAST ONCE A YEAR.THE COMMITTEE IS MANDATED BY ITS CHARTER TO REVIEW EXECUTIVE AND OTHER KEY EMPLOYEE PERFORMANCE CONSISTENT WITH THE GOALS AND OBJECTIVES OF THE FOUNDATION AS DETERMINED BY THE BOARD OF TRUSTEES AND TO DETERMINE AN APPROPRIATE LEVEL OF COMPENSATION IN LIGHT OF THIS PERFORMANCE REVIEW AND USING OTHER SUBSTANTIATING DATA SURVEYS ON CURRENT COMPENSATION RATES FOR SIMILAR POSITIONS IN OTHER COMPARABLE NONPROFITS IN THE NEW YORK CITY AREA.THE COMMITTEE'S DECISION IS DOCUMENTED IN A CONTEMPORANEOUSLY WRITTEN FORMAT (COMPENSATION COMMITTEE MINUTES) INDICATING THE DATE OF THE MEETING, THE MEMBERS PRESENT, AND THE COMPARABLE DATA USED TO MAKE THE DECISION.THE COMPENSATION REVIEW PROCESS FOR THE PRESIDENT/CEO AND EXECUTIVE VICE PRESIDENT WAS LAST UNDERTAKEN ON DECEMBER 9, 2015.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION MAKES ITS FORM 990 AND AUDITED FINANCIAL STATEMENTS AVAILABLE FOR PUBLIC INSPECTION AS REQUIRED UNDER SECTION 6104 OF THE INTERNAL REVENUE CODE BY POSTING IT ON THEIR WEBSITE AS WELL AS OTHER SIMILAR WEBSITES SUCH AS WWW.GUIDESTAR.ORG. IN ADDITION, THE FORM 990 AND AUDITED FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND OTHER POLICIES ARE AVAILABLE UPON WRITTEN REQUEST AT 110 E. 42ND STREET, FL 16, NEW YORK, NY 10017 OR BY CALLING THE ORGANIZATION DIRECTLY AT (800) 259-4636 OR (212) 915-1321.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XII, LINE 2C:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION HAS AN AUDIT COMMITTEE THAT IS RESPONSIBLE FOR OVERSIGHT OF THE AUDIT AND ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT. THE PROCESS HAS NOT CHANGED FROM THE PREVIOUS YEAR.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>